Patrick Campbell

Ritlecitinib (Litfulo) 50 mg showed long-term efficacy in treating #AlopeciaAreata in patients aged 12 and older, new data suggest, with significant SALT score improvements over 24 months. Learn more about these findings, presented at #DERM2025, here: hcplive.com/view/phase-3-f…

New findings show chronic spontaneous #urticaria (#CSU) affects 0.78% of U.S. adults, far more than previous estimates. Most patients face high mental, physical, and work-related burdens, yet few see dermatologists. hubs.ly/Q03y-tLZ0

I am here in Las Vegas 🌴 for the @DermNPPA conference #DERM2025! I've been interviewing a variety of leaders in #dermatology such as Drs. Linda Stein Gold, Suneel Chilukuri, & Adam Friedman, so stay updated with our coverage! 🔗 View updates here: hcplive.com/conference/der…

New from #DERM2025: Deuruxolitinib 8 mg BID significantly improved hair satisfaction in severe alopecia areata patients, with 95.7% reporting satisfaction by week 24. View more here: hcplive.com/view/patient-r…

New episode of #KidneyCompass coming soon! Follow @HCPLiveNews for the latest releases of this podcast and many others!

From FDA approvals to new clinical trial data and progress in xenotransplantation, the first half of 2025 was full of innovations in #nephrology. Check out our recap for a full breakdown of what shaped the first 6 months of the year: hubs.li/Q03wy8Zm0

A new frontier in cardiometabolic disease? Check out this preview from a recent #DiabetesDialogue and use the link below for the full #ADA2025 episode: hcplive.com/view/diabetes-…

Day 3 of #SDPA2025 completed!✅ Are you up-to-date on everything covered at the SDPA Conference? If not, check out HCPLive's highlights from the meeting to keep informed: hcplive.com/conference/soc…

Several helpful tips on diagnosing and managing #ChronicHandEczema (CHE) were highlighted in a recent interview with Dr. Adam Friedman of @GW_MFA. His interview at #SDPA2025 highlights several points often unnoticed by dermatologists, PAs, & NPs. 🔗View: hcplive.com/view/tips-opti…

Explore the real challenges women in medicine face, including work-life balance, leadership barriers, and gender bias. Watch Now: hubs.li/Q03tFGrJ0 #TheMedicalSisterhood

NEW: Nektar's 'rezpegaldesleukin' showed significant efficacy in improving EASI scores in moderate-to-severe #AtopicDermatitis patients at 16 weeks. Want to learn more about these new data?🤔 🔗View our summary here: hcplive.com/view/new-findi…

Once science fiction, now a reality: The QWINT-1 study shows a once-weekly insulin named efsitora alfa is just as effective in lowering blood glucose as daily basal insulin in people w/ #Type2Diabetes starting insulin. hcplive.com/view/qwint-1-w… #ADASciSessions #ADA2025 #Insulin

Doctors @MasriAhmadMD, @DorbalaSharmila, @abouezzeddine, @premsoman123 & Daniel Judge highlight how evolving ATTR-CM treatments stress the need for early diagnosis, faster detection, and timely use of new therapies. Watch now: hubs.li/Q03s2FsB0

🎥 Don’t miss this exclusive interview with @DrMBWesterman on the latest survey findings in NMIBC treatment. She breaks down why uptake is slow and what needs to change. Watch the interview here ⬇️ urologytimes.com/view/survey-ne…

Baseline use of #SGLT2i in recent trials enrolling patients with #IgAN: Listen to the full podcast discussion between me, @SWadhwaniMD & @VladoPerkovic: hcplive.com/view/kidney-co… #ERA25 #kidneycompass #sibeprenlimab #VISIONARY

New at #HiD25: we spoke with Robert Califf, MD, former commissioner of the FDA, to discuss his presentation on the shortcomings of technological advancements and the industry's inability to collate these massive amounts of data. Watch the full interview: hubs.li/Q03rbqGH0

Important data from @JACCJournals presented by @ambarish4786 NTproBNP tends to increase at 1 yr f/u with weight loss from lifestyle change. Compared with decreases in NTproBNP with #GLP1RA assisted weight loss observed in #HFpEF RCTs @HeartinDiabetes @YHandelsmanMD #HID2025

Hear from @jllbmd @UMJFKcards about findings from the ARISE-HF trial of AT-001 for exercise capacity preservation in people with diabetic #cardiomyopathy and racial/ethnic differences observed among the cohort. #HID2025 #HID25 @HeartinDiabetes hcplive.com/view/recognizi…